ELEDON PHARMACEUTICALS INC (ELDN): Institutional Ownership
Hedge funds and institutional managers reporting a position in ELDN · Health Care. Based on the most recent 13F filing from each holder, sourced from SEC EDGAR.
Reported Holders
8
13F filers
Aggregate Value
$6.3M
Across holders
Last Price
$3.78
2026-06-26
Sector
Health Care
GICS
Holder activity4 new2 added2 reduced
| Manager⇅ | Type⇅ | Shares⇅ | Market Value▼ | % of Total⇅ | % of Portfolio⇅ | Action⇅ | QoQ Change⇅ | Quarter⇅ |
|---|---|---|---|---|---|---|---|---|
| Schonfeld Strategic Advisors LLC CIK 0001665241 | Hedge Fund | 998K | $2.7M | 42.6% | 0.0% | New | — | Q2 2025 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. CIK 0001165408 | Hedge Fund | 410K | $2.5M | 39.9% | 0.0% | New | — | Q3 2021 |
| Brevan Howard Capital Management LP CIK 0001512857 | Hedge Fund | 229K | $680K | 10.7% | 0.0% | Added | +$98K | Q1 2026 |
| BALYASNY ASSET MANAGEMENT LLC CIK 0001218710 | Hedge Fund | 62K | $209K | 3.3% | 0.0% | New | — | Q1 2025 |
| CITADEL ADVISORS LLC CIK 0001423053 | Hedge Fund | 45K | $139K | 2.2% | 0.0% | Added | +$45K | Q1 2026 |
| RENAISSANCE TECHNOLOGIES LLC CIK 0001037389 | Hedge Fund | 25K | $76K | 1.2% | 0.0% | Reduced | $-469K | Q1 2026 |
| MARSHALL WACE, LLP CIK 0001318757 | Hedge Fund | 2K | $3K | 0.1% | 0.0% | New | — | Q4 2025 |
| AQR CAPITAL MANAGEMENT LLC CIK 0001167557 | Hedge Fund | 46 | $142 | 0.0% | 0.0% | Reduced | $-114 | Q1 2026 |
New
Hedge Fund
$2.7M· 42.6% of total· 0.0% port· 998K sh· — QoQ· Q2 2025
New
Hedge Fund
$2.5M· 39.9% of total· 0.0% port· 410K sh· — QoQ· Q3 2021
Added
Hedge Fund
$680K· 10.7% of total· 0.0% port· 229K sh· +$98K QoQ· Q1 2026
New
Hedge Fund
$209K· 3.3% of total· 0.0% port· 62K sh· — QoQ· Q1 2025
Added
Hedge Fund
$139K· 2.2% of total· 0.0% port· 45K sh· +$45K QoQ· Q1 2026
Reduced
Hedge Fund
$76K· 1.2% of total· 0.0% port· 25K sh· $-469K QoQ· Q1 2026
New
Hedge Fund
$3K· 0.1% of total· 0.0% port· 2K sh· — QoQ· Q4 2025
Reduced
Hedge Fund
$142· 0.0% of total· 0.0% port· 46 sh· $-114 QoQ· Q1 2026